Importance of the field: Whilst mutant BRAFV600E is readily targeted by RAF inhibitors in melanoma, paradoxical activation of ERK1/2 signalling in cells with wild-type RAF and dimer-mediated acquired resistance to RAF inhibitors has limited their wider use. The gene discussed is MAPK3; the disease is melanoma.